These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 21479172)

  • 1. A melanoma molecular disease model.
    Vidwans SJ; Flaherty KT; Fisher DE; Tenenbaum JM; Travers MD; Shrager J
    PLoS One; 2011 Mar; 6(3):e18257. PubMed ID: 21479172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanoma genetics: the other side.
    Bis S; Tsao H
    Clin Dermatol; 2013; 31(2):148-55. PubMed ID: 23438378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin.
    Whiteman DC; Pavan WJ; Bastian BC
    Pigment Cell Melanoma Res; 2011 Oct; 24(5):879-97. PubMed ID: 21707960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted therapies and immune checkpoint inhibitors in the treatment of metastatic melanoma patients: a guide and update for pathologists.
    Kakavand H; Wilmott JS; Long GV; Scolyer RA
    Pathology; 2016 Feb; 48(2):194-202. PubMed ID: 27020392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New strategies in melanoma: molecular testing in advanced disease.
    Woodman SE; Lazar AJ; Aldape KD; Davies MA
    Clin Cancer Res; 2012 Mar; 18(5):1195-200. PubMed ID: 22275506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent patents on melanoma with focus on genetic strategies.
    Gramiccia T; Saraceno R; Stefani AD; Chimenti S
    Recent Pat Antiinfect Drug Discov; 2008 Jun; 3(2):136-44. PubMed ID: 18673127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new era: melanoma genetics and therapeutics.
    Ko JM; Fisher DE
    J Pathol; 2011 Jan; 223(2):241-50. PubMed ID: 21125678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roads to melanoma: Key pathways and emerging players in melanoma progression and oncogenic signaling.
    Paluncic J; Kovacevic Z; Jansson PJ; Kalinowski D; Merlot AM; Huang ML; Lok HC; Sahni S; Lane DJ; Richardson DR
    Biochim Biophys Acta; 2016 Apr; 1863(4):770-84. PubMed ID: 26844774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic signaling in uveal melanoma.
    Park JJ; Diefenbach RJ; Joshua AM; Kefford RF; Carlino MS; Rizos H
    Pigment Cell Melanoma Res; 2018 Nov; 31(6):661-672. PubMed ID: 29738114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
    Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
    J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole genome and exome sequencing of melanoma: a step toward personalized targeted therapy.
    Dutton-Regester K; Hayward NK
    Adv Pharmacol; 2012; 65():399-435. PubMed ID: 22959033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of gene expression and pathway signatures to characterize the complexity of human melanoma.
    Freedman JA; Tyler DS; Nevins JR; Augustine CK
    Am J Pathol; 2011 Jun; 178(6):2513-22. PubMed ID: 21641377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetic basis of new treatment modalities in melanoma.
    Kunz M
    Curr Drug Targets; 2015; 16(3):233-48. PubMed ID: 25654738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active surrender.
    Collisson EA
    Pigment Cell Melanoma Res; 2012 May; 25(3):292-3. PubMed ID: 22629566
    [No Abstract]   [Full Text] [Related]  

  • 15. Toward a molecular classification of melanoma.
    Fecher LA; Cummings SD; Keefe MJ; Alani RM
    J Clin Oncol; 2007 Apr; 25(12):1606-20. PubMed ID: 17443002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent discoveries in the genetics of melanoma and their therapeutic implications.
    Marquette A; Bagot M; Bensussan A; Dumaz N
    Arch Immunol Ther Exp (Warsz); 2007; 55(6):363-72. PubMed ID: 18060370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment implications of the emerging molecular classification system for melanoma.
    Romano E; Schwartz GK; Chapman PB; Wolchock JD; Carvajal RD
    Lancet Oncol; 2011 Sep; 12(9):913-22. PubMed ID: 21349766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular-targeted therapy in malignant melanoma.
    Sullivan RJ; Atkins MB
    Expert Rev Anticancer Ther; 2009 May; 9(5):567-81. PubMed ID: 19445574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in uveal melanoma treatment.
    Álvarez-Rodríguez B; Latorre A; Posch C; Somoza Á
    Med Res Rev; 2017 Nov; 37(6):1350-1372. PubMed ID: 28759124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in targeted therapy for unresectable melanoma: new drugs and combinations.
    Hao M; Song F; Du X; Wang G; Yang Y; Chen K; Yang J
    Cancer Lett; 2015 Apr; 359(1):1-8. PubMed ID: 25578781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.